Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2022 | Story Anthony Mthembu | Photo Supplied
Letsatsi Lekhooa
Letsatsi Lekhooa, a UFS student who was selected to be part of the COP27 Simulation Model.

Nearly 150 students from across the world will gather in Egypt for the COP27 Simulation Model from 9 September to mid- October 2022. Among them will be Letsatsi Lekhooa, a Master of Science student specialising in Climate Change from the University of the Free State (UFS). 

Lekhooa was one of 150 students from a pool of more than 1 800 applicants across the world who were selected to be part of this prestigious initiative. “This opportunity is appealing, because as young people we need to work hard to not only ensure that we break through walls, but to also represent our university well everywhere we go,” Lekhooa indicated.

The COP27 Simulation Model

The COP27 Simulation Model, which is organised by the British University in Egypt along with the United Nations Development Programme (UNDP), is a worldwide climate conference led by and targeted at the youth. The conference is important for several reasons, such as encouraging conversations around climate action among the youth. As it stands, the initiative is split into two categories, which include the hybrid capacity-building programme that started in September, and the COP27 Mock Conference set to begin in October. Lekhooa is currently engaged in the online capacity-building programme, which he describes as a learning curve. “Every day I learn something new, and I enjoy it because the process is assisting me in learning more about this climate change issue,” Lekhooa expressed. 

The benefits of attending the COP27 Mock Conference

Although the first leg of the COP27 Simulation Model is online, Lekhooa will get the opportunity to travel to Egypt and physically be part of the COP27 Mock Conference on the campus of the British University in Egypt. As such, he hopes to take away as much as possible from the experience. “I hope to learn about the ways in which I can better communicate this climate change issue, not only in my home country of Lesotho, but generally in Southern Africa,” said Lekhooa. Furthermore, through his interactions with international scholars, he hopes to create and encourage a collaborative spirit to battle climate change. 

The experience does not only serve as a learning curve for Lekhooa, but it is also one of the key steps that will allow him to reach a life goal. “I would like to be an international consultant in bodies such as the Intergovernmental Panel on Climate Change (IPCC), and the United Nations Framework Convention on Climate Change (UNFCCC), as they play a key role in making decisions on climate change,” Lekhooa highlighted.

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept